• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肿瘤免疫学应用的特别设计微流控芯片中细胞间串扰的高通量分析。

High-throughput analysis of cell-cell crosstalk in ad hoc designed microfluidic chips for oncoimmunology applications.

作者信息

Mencattini Arianna, De Ninno Adele, Mancini Jacopo, Businaro Luca, Martinelli Eugenio, Schiavoni Giovanna, Mattei Fabrizio

机构信息

Department of Electronic Engineering, University of Rome Tor Vergata, Rome, Italy.

Institute for Photonics and Nanotechnology, Italian National Research Council, Rome, Italy; Department of Civil Engineering and Computer Science, University of Rome Tor Vergata, Rome, Italy.

出版信息

Methods Enzymol. 2020;632:479-502. doi: 10.1016/bs.mie.2019.06.012. Epub 2019 Jul 26.

DOI:10.1016/bs.mie.2019.06.012
PMID:32000911
Abstract

Understanding the interactions between immune and cancer cells occurring within the tumor microenvironment is a prerequisite for successful and personalized anti-cancer therapies. Microfluidic devices, coupled to advanced microscopy systems and automated analytical tools, can represent an innovative approach for high-throughput investigations on immune cell-cancer interactions. In order to study such interactions and to evaluate how therapeutic agents can affect this crosstalk, we employed two ad hoc fabricated microfluidic platforms reproducing advanced 2D or 3D tumor immune microenvironments. In the first type of chip, we confronted the capacity of tumor cells embedded in Matrigel containing one drug or Matrigel containing a combination of two drugs to attract differentially immune cells, by fluorescence microscopy analyses. In the second chip, we investigated the migratory/interaction response of naïve immune cells to danger signals emanated from tumor cells treated with an immunogenic drug, by time-lapse microscopy and automated tracking analysis. We demonstrate that microfluidic platforms and their associated high-throughput computed analyses can represent versatile and smart systems to: (i) monitor and quantify the recruitment and interactions of the immune cells with cancer in a controlled environment, (ii) evaluate the immunogenic effects of anti-cancer therapeutic agents and (iii) evaluate the immunogenic efficacy of combinatorial regimens with respect to single agents.

摘要

了解肿瘤微环境中免疫细胞与癌细胞之间的相互作用是成功实施个性化抗癌治疗的前提条件。微流控装置与先进的显微镜系统及自动化分析工具相结合,可为免疫细胞与癌细胞相互作用的高通量研究提供一种创新方法。为了研究此类相互作用并评估治疗药物如何影响这种相互作用,我们采用了两个专门制造的微流控平台,它们能够重现先进的二维或三维肿瘤免疫微环境。在第一种芯片中,我们通过荧光显微镜分析,比较了包埋于含有一种药物的基质胶或含有两种药物组合的基质胶中的肿瘤细胞吸引不同免疫细胞的能力。在第二种芯片中,我们通过延时显微镜和自动跟踪分析,研究了未激活的免疫细胞对经免疫原性药物处理的肿瘤细胞发出的危险信号的迁移/相互作用反应。我们证明,微流控平台及其相关的高通量计算分析可代表多功能智能系统,用于:(i)在可控环境中监测和量化免疫细胞与癌细胞的募集及相互作用,(ii)评估抗癌治疗药物的免疫原性效应,以及(iii)评估联合用药方案相对于单一药物的免疫原性疗效。

相似文献

1
High-throughput analysis of cell-cell crosstalk in ad hoc designed microfluidic chips for oncoimmunology applications.用于肿瘤免疫学应用的特别设计微流控芯片中细胞间串扰的高通量分析。
Methods Enzymol. 2020;632:479-502. doi: 10.1016/bs.mie.2019.06.012. Epub 2019 Jul 26.
2
Drug testing of monodisperse arrays of live microdissected tumors using a valved multiwell microfluidic platform.使用阀控多井微流控平台对活体微切割肿瘤的单分散阵列进行药物测试。
Lab Chip. 2024 May 14;24(10):2683-2699. doi: 10.1039/d4lc00016a.
3
In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.用于测试头颈部癌症患者个体化免疫疗法的体外人源化 3D 微流控芯片。
Exp Cell Res. 2019 Oct 15;383(2):111508. doi: 10.1016/j.yexcr.2019.111508. Epub 2019 Jul 26.
4
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments.用于剖析体外肿瘤微环境中免疫反应的微流控共培养模型
J Vis Exp. 2021 Apr 30(170). doi: 10.3791/61895.
5
Advancing Point-of-Care Applications with Droplet Microfluidics: From Single-Cell to Multicellular Analysis.微流控液滴技术在即时检测应用中的进展:从单细胞分析到多细胞分析。
Annu Rev Biomed Eng. 2024 Jul;26(1):119-139. doi: 10.1146/annurev-bioeng-110222-102142. Epub 2024 Jun 20.
6
Microfluidic cell chips for high-throughput drug screening.用于高通量药物筛选的微流控细胞芯片
Bioanalysis. 2016 May;8(9):921-37. doi: 10.4155/bio-2016-0028. Epub 2016 Apr 13.
7
Selective Targeting of Tumor Cells in a Microfluidic Tumor Model with Multiple Cell Types.在具有多种细胞类型的微流控肿瘤模型中对肿瘤细胞进行选择性靶向。
Methods Mol Biol. 2024;2804:237-251. doi: 10.1007/978-1-0716-3850-7_15.
8
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development.微流控技术在肿瘤微环境中的建模及其在抗癌药物研发中的应用。
Lab Chip. 2019 Jan 29;19(3):369-386. doi: 10.1039/c8lc00970h.
9
Microfluidics for studying metastatic patterns of lung cancer.微流控技术在研究肺癌转移模式中的应用。
J Nanobiotechnology. 2019 May 27;17(1):71. doi: 10.1186/s12951-019-0492-0.
10
Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment.肿瘤细胞与免疫细胞的串扰:在微流控环境中探索复杂动态。
Lab Chip. 2013 Jan 21;13(2):229-39. doi: 10.1039/c2lc40887b. Epub 2012 Oct 30.

引用本文的文献

1
Decitabine co-operates with the IL-33/ST2 axis modifying the tumor microenvironment and improving the response to PD-1 blockade in melanoma.地西他滨与IL-33/ST2轴协同作用,改变肿瘤微环境并改善黑色素瘤对PD-1阻断的反应。
J Exp Clin Cancer Res. 2025 May 2;44(1):137. doi: 10.1186/s13046-025-03381-z.
2
Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers.探寻微流控技术在头颈癌早期诊断与个性化治疗中的潜力
Cancers (Basel). 2023 Jul 31;15(15):3894. doi: 10.3390/cancers15153894.
3
Engineering complexity in human tissue models of cancer.
癌症人体组织模型的工程复杂性。
Adv Drug Deliv Rev. 2022 May;184:114181. doi: 10.1016/j.addr.2022.114181. Epub 2022 Mar 9.
4
Tackling Current Biomedical Challenges With Frontier Biofabrication and Organ-On-A-Chip Technologies.利用前沿生物制造和芯片器官技术应对当前的生物医学挑战。
Front Bioeng Biotechnol. 2021 Sep 16;9:732130. doi: 10.3389/fbioe.2021.732130. eCollection 2021.
5
Oncoimmunology Meets Organs-on-Chip.肿瘤免疫学与器官芯片技术的结合。
Front Mol Biosci. 2021 Mar 26;8:627454. doi: 10.3389/fmolb.2021.627454. eCollection 2021.